Companies › ELTX
Elicio Therapeutics Inc (ELTX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001601485 · EDGAR filings · Updated 2026-07-17
Elicio Therapeutics Inc (ELTX) has reported institutional ownership of 14.1%, with 47 institutional managers holding positions valued at $28.2M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-16 — SCHEDULE 13G filed
- 2026-07-08 — SCHEDULE 13G/A filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Elicio Therapeutics Inc has 47 institutional holders and institutional ownership of 14.1%.
Insider activity
Insiders reported 5 transactions (0 buys, 0 sells) across 4 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
CAPSOVISION INC (CV) · ALPHA TAU MEDICAL LTD (DRTS) · EXAGEN INC (XGN) · CANOPY GROWTH CORPORATION (CGC) · ACCURAY INC DEL (ARAY) · SCYNEXIS INC (SCYX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.